Altesa BioSciences

About Altesa BioSciences

Altesa BioSciences is a clinical-stage biopharmaceutical company focused on preventing and treating viral respiratory infections to reduce COPD and asthma exacerbations, starting with rhinovirus. The company aims to disrupt the COPD treatment paradigm by developing safe, oral antiviral medicines that treat infections early to prevent downstream complications such as hospitalizations. It operates in the United States with a focus on advancing antiviral therapies like vapendavir and related capsid inhibitors through clinical development. Headquartered in College Park, Georgia, Altesa is dedicated to improving respiratory health for millions of patients affected by COPD and related conditions.